JNJ 26854165 100mg

JNJ-26854165 is one of p53-activating agents and synergizes with AraC or doxorubicin to induce p53-mediated apoptosis and may provide a novel therapeutic approach for the treatment of acute leukemias.

Price Not Available 100mg JNJ 26854165 100mg Supplier Page

Trivial name	JNJ 26854165 100mg
Catalog Number	A10491-100
Alternative Name(s)	N-[2-(1H-Indol-3-yl)ethyl]-N'-(4-pyridinyl)-1,4-benzenediamine
Molecular Formula	C21H20N4
CAS#	881202-45-5
SMILES	C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4
Size	100mg
Supplier Page	http://www.adooq.com/jnj-26854165.html